Intensity-Modulated Radiotherapy for Head-and-Neck Cancer in the Community Setting

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 4, 2008, Pages 1075-1081

  Seung, Steven ^a,b   Bae, Joseph ^c   Solhjem, Matthew ^a   Bader, Stephen ^a   Gannett, David ^a   Hansen, Eric K ^a   Louie, Jeannie ^a   Underhill, Kelly ^a   Cha, Christine ^a  

^a Oregon Clinic   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

^c LEWIS AND CLARK COLLEGE   (United States)

Author keywords

Intensity modulated radiotherapy; Nasopharyngeal cancer; Oropharyngeal cancer

Indexed keywords

CHEMOTHERAPY; CUSTOMER SATISFACTION; PHYSICAL THERAPY; QUALITY ASSURANCE; QUALITY FUNCTION DEPLOYMENT; RADIOTHERAPY; RISK PERCEPTION; TOTAL QUALITY MANAGEMENT; TOXICITY;

ACUTE TOXICITIES; CONCURRENT CHEMOTHERAPIES; INTENSITY-MODULATED RADIOTHERAPY; LOCAL CONTROLS; MUCOSITIS; NASOPHARYNGEAL CANCER; NECK CANCERS; OROPHARYNGEAL CANCER; OROPHARYNGEAL CANCERS; OROPHARYNX; OVERALL SURVIVAL RATES; PLANNING TARGET VOLUMES; RADIATION THERAPIES; SIMULTANEOUS INTEGRATED BOOSTS; STAGE III; XEROSTOMIA;

QUALITY CONTROL;

ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; COMMUNITY ASSESSMENT; DERMATITIS; FOLLOW UP; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; ORGAN DISTRIBUTION; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY HEALTH SERVICES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OREGON; OROPHARYNGEAL NEOPLASMS; RADIODERMATITIS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 54049095253     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.016     Document Type: Article

References (23)

1. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
2. Lee N., Xia P., Fischbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
3. Chao K.S., Ozyigit G., Blanco A.I., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys 59 (2004) 43-50
4. Huang K., Lee N., and Xia P. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: A single institutional experience (Abstr.). Int J Radiat Oncol Biol Phys 57 (2003) S302
5. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
6. Henson B.S., Inglehart M.R., Eisbruch A., et al. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 37 (2001) 84-93
7. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
8. Chao K.S., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
9. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
10. Kaplan E., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
11. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
12. Hodge C.W., Bentzen S.M., Wong G., et al. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys 69 (2007) 1032-1041
13. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
14. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
15. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
16. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
17. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
18. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
19. Lin A., Kim H.M., Terrell J.E., et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
20. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
21. Eisbruch A., Dawson L.A., Kim H.M., et al. Conformal and intensity modulated irradiation of head and neck cancer: The potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 53 (1999) 271-275
22. Staar S., Rudat V., Stuetzer H., et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1161-1171
23. Eisbruch A., Levendag P.C., Feng F.Y., et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 69 2 Suppl. (2007) S40-S42